Driving the Future of Needle-Free Transdermal Delivery

---

As a cutting-edge biotechnology entity, PassPort Technologies Inc. (PPTI) is committed to the swift development and patient delivery of exceptional pharmaceuticals through the PassPort system. This innovative company aims to constantly develop technologies that serve not only the pharmaceutical industry but also broader life sciences sectors. PassPort Technologies' mission is to advance global health outcomes.

Located in San Diego, California, at the new GENESIS Science Center campus, PassPort Technologies, Inc. is dedicated to the development of therapeutics through advanced drug delivery systems. Founded after being spun out of Nitto Denko Corporation in July 2019, PassPort Technologies Inc. aims to further R&D efforts for the commercialization of the PassPort® transdermal platform. 

With strong technical knowledge and decades of experience in both pharmaceutical sciences and engineering, the team at PassPort Technologies possesses the necessary expertise in transdermal formulation and medical device development that the PassPort technology system requires.

PassPort Technologies Inc. is focused on creating enhanced pharmaceutical products through its patent-protected drug delivery platform. This innovative approach presents a unique drug repositioning opportunity for companies that already provide approved therapeutics and vaccines, as well as for those working on new NCE candidates. 

PassPort Technologies collaborates with a diverse array of partners, ranging from top academic institutions to small specialty pharma groups and multinational pharmaceutical companies. With the PassPort® System, we can swiftly formulate and assess our partners' drug candidates in-house.

PassPort Technologies Inc. is focused on the future of medication management and patient adherence. By leveraging innovative solutions, Passport Technologies will continue to advance the PassPort® System, enabling the integration of new wireless communication and data management technologies.